☆ 4.7 Article

The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Obstetrics & Gynecology

Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway

Ting Zhu et al.

Summary: This study found that irisin/FNDC5 was highly expressed in epithelial ovarian cancer tissues and regulated epithelial-mesenchymal transition through the PI3K/Akt signaling pathway, thereby inhibiting the proliferation, invasion, and migration of ovarian cancer cells.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2022)

Add to Collection

Article Medicine, Research & Experimental

Significance of Irisin (FNDC5) Expression in Colorectal Cancer

Slawomir Wozniak et al.

Summary: This study investigated the expression level of irisin in patients with colorectal cancer (CRC) and found that irisin expression was higher in cancer cells compared to control tissues. The study also observed a significant difference in irisin expression between different stages of CRC, indicating its potential usefulness as a marker in CRC.

IN VIVO (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Transcriptional repression of E-cadherin in nickel-exposed lung epithelial cells mediated by loss of Sp1 binding at the promoter

Xiaoru Zhang et al.

Summary: This study demonstrates that nickel exposure leads to persistent downregulation of E-cadherin by causing loss of Sp1 binding at the CDH1 promoter, which induces EMT. Continuous upregulation of ZEB1 is also a key factor in the loss of E-cadherin, and knocking out ZEB1 using CRISPR-Cas9 technology can restore E-cadherin expression.

MOLECULAR CARCINOGENESIS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx

Agnieszka Pinkowska et al.

Summary: This study investigated the expression of irisin in Laryngeal Squamous Cell Carcinoma (LSCC) and found that irisin expression levels were significantly increased in LSCC compared to other benign conditions. There was a positive correlation between irisin and proliferation markers, as well as clinicopathological factors. These findings suggest the potential role of irisin as a biomarker in the diagnostic process of LSCC.

BIOMOLECULES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Expression of Irisin/FNDC5 in Breast Cancer

Kamil Cebulski et al.

Summary: This study aimed to determine the expression levels of irisin in breast cancer tissues and investigate its association with clinicopathological factors and survival rate. The results showed that BC patients had higher levels of FNDC5/irisin expression compared to normal breast tissue. Higher FNDC5/irisin expression was associated with no lymph node metastases and longer overall survival in BC patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Implication of Irisin in Different Types of Cancer: A Systematic Review and Meta-Analysis

Maria Vliora et al.

Summary: Irisin plays a role in cancer, with decreased expression in cancer patients making it a useful biomarker for diagnosis. It may have a significant role in tumor progression and metastasis by promoting cell proliferation and migration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Association of Irisin/FNDC5 with ERRα and PGC-1α Expression in NSCLC

Katarzyna Nowinska et al.

Summary: This study found a negative correlation between ERR alpha and tumor size, disease stages, and lymph node metastases in non-small cell lung cancer, while higher ERR alpha expression was significantly associated with longer overall survival in the adenocarcinoma subtype. Additionally, a moderate positive correlation was observed between FNDC5 mRNA and ESRRA mRNA in NSCLCs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Endocrinology & Metabolism

Irisin: circulating levels in serum and its relation to gonadal axis

Yunyao Luo et al.

Summary: This review examines the role of Irisin in the gonadal axis and its potential effects on reproduction and fertility. It discusses the circulating levels of Irisin, the mechanisms involved in its secretion and regulation, and its relationship with PCOS, BMI, insulin resistance, and hyperandrogenism. Animal interventional studies and in vitro experiments are presented to support the novel effects of Irisin on the gonadal axis.

ENDOCRINE (2022)

Add to Collection

Review Endocrinology & Metabolism

Progress and Challenges in the Biology of FNDC5 and Irisin

Steffen Maak et al.

Summary: The transmembrane protein FNDC5 was discovered in 2002 and later identified to be expressed in skeletal muscle, heart, and brain. A study in 2012 proposed that skeletal muscle FNDC5, when cleaved in response to exercise, could induce browning in white adipose tissue, leading to the release of irisin. More than 1000 papers have since been published exploring the roles of irisin, especially in adipose tissue and metabolism.

ENDOCRINE REVIEWS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Immunology

SNAIL1: Linking Tumor Metastasis to Immune Evasion

Xiaolong Tang et al.

Summary: Snail1, a transcription factor, plays a critical role in tumor metastasis, immune evasion, and suppression. Its stability is controlled by various signaling pathways and the ubiquitin-proteasome system, while its methylation and acetylation also impact tumor metastasis.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Oncology

Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors

Sikiru O. Imodoye et al.

Summary: EMT is a crucial physiological process in human development and wound healing, but it can be hijacked in pathological conditions like tumor metastasis, posing a major challenge in cancer treatment. Master regulators called EMT transcription factors play a significant role in driving molecular rewiring that leads to tumor initiation, progression, EMT, metastasis, and colonization. Understanding the molecular interplay involving EMT signaling pathways is essential for developing effective therapeutic targets to overcome drug resistance in cancer treatment.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Cell Biology

The Role of Irisin in Cancer Disease

Agnieszka Pinkowska et al.

Summary: Irisin is a adipomyokine that regulates metabolic processes and inflammation, potentially influencing cancer as well. It is secreted not only by skeletal muscles, but also present in various healthy tissues and organs. Studies have shown that Irisin can promote the transformation of white adipose tissue, inhibit the proliferation and migration of cancer cells.

CELLS (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Review of Research on the Role of Irisin in Tumors

Deguo Zhang et al.

ONCOTARGETS AND THERAPY (2020)

Add to Collection

Review Oncology

Epithelial-Mesenchymal Transition in Cancer: A Historical Overview

Domenico Ribatti et al.

TRANSLATIONAL ONCOLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway

Deguo Zhang et al.

ONCOTARGETS AND THERAPY (2019)

Add to Collection

Review Cell Biology

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges

Chin-Yap Loh et al.

CELLS (2019)

Add to Collection

Article Oncology

Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-Small Cell Lung Cancer

Katarzyna Nowinska et al.

CANCERS (2019)

Add to Collection

Article Medicine, General & Internal

Serum irisin associates with breast cancer to spinal metastasis

Zheng-ping Zhang et al.

MEDICINE (2018)

Add to Collection

Review Pathology

The new TNM-based staging of breast cancer

Gabor Cserni et al.

VIRCHOWS ARCHIV (2018)

Add to Collection

Article Multidisciplinary Sciences

Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway

Jiayu Liu et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Review Oncology

Epithelial-mesenchymal transition in tumor metastasis

Kay T. Yeung et al.

MOLECULAR ONCOLOGY (2017)

Add to Collection

Article Oncology

Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway

Gang Kong et al.

ONCOLOGY REPORTS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma

Guangjun Shi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition

Lei Shao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Add to Collection

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Add to Collection

Article Oncology

Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics

Xeni Provatopoulou et al.

BMC CANCER (2015)

Add to Collection

Article Oncology

Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro

Nicholas P. Gannon et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Add to Collection

Article Endocrinology & Metabolism

Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines

Hyun-Seuk Moon et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2014)

Add to Collection

Article Oncology

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer

Antoinette Hollestelle et al.

BREAST CANCER RESEARCH AND TREATMENT (2013)

Add to Collection

Article Oncology

The Role of Snail in EMT and Tumorigenesis

Yifan Wang et al.

CURRENT CANCER DRUG TARGETS (2013)

Add to Collection

Review Biochemistry & Molecular Biology

The PGC-1/ERR signaling axis in cancer

G. Deblois et al.

ONCOGENE (2013)

Add to Collection

Review Oncology

Tumor and its microenvironment: A synergistic interplay

Veronica Catalano et al.

SEMINARS IN CANCER BIOLOGY (2013)

Add to Collection

Review Cell Biology

Links between metabolism and cancer

Chi V. Dang

GENES & DEVELOPMENT (2012)

Add to Collection

Article Multidisciplinary Sciences

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

Pontus Bostroem et al.

NATURE (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.